Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 33

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 3
Chunk 33
---
 charter setting forth the required composition, meeting procedures and other matters related to the terms
of operation of the committee. The charter also describes the responsibilities of the audit committee consistent with the rules of the
SEC and the Nasdaq Listing Rules, which include, among others:

  retaining and terminating the services of our independent auditors, subject to the approval of the board of directors and shareholders;  

  pre-approval of audit and non-audit services to be provided by the independent auditors;  

  reviewing with management and our independent directors our financial reports prior to their submission to the SEC; and  

  approval of certain transactions with office holders and other related-party transactions.  

The charter of the audit committee is available on our website.
The contents of that website do not constitute a part of this Annual Report.

Our audit committee provides assistance to our board of directors
in fulfilling its legal and fiduciary obligations in matters involving our accounting, auditing, financial reporting, internal control
and legal compliance functions by pre-approving the services performed by our independent accountants and reviewing their reports regarding
our accounting practices and systems of internal control over financial reporting. Our audit committee also oversees the audit efforts
of our independent accountants and takes those actions that it deems necessary to satisfy itself that the accountants are independent
of management.

Additionally, under the Companies Law, an audit committee is required,
among other things, to (i) identify deficiencies in the administration of the company (including by consulting with the internal auditor),
and recommend remedial actions with respect to such deficiencies, (ii) review and approve certain related party transactions, including
determining whether or not such transactions are extraordinary transactions or insignificant transactions, and (iii) adopt procedures
with respect to processing employee complaints in connection with deficiencies in the administration of the company, and the appropriate
means of protection afforded to such employees. In addition, the audit committee is responsible for overseeing the internal control procedures
of the company. Under the Companies Law, the approval of the audit committee is required for specified actions and transactions with office
holders and controlling shareholders. See “ - Approval of Related Party Transactions under Israeli Law.”

Compensation and Nominating Committee

Our compensation and nominating committee, or compensation committee,
consists of Mr. Dan Falk, Mr. Nir Nimrodi and Dr. Oded Shoseyov. Mr. Falk serves as the Chairperson of the committee.

Requirements as to Composition

Following the promulgation of the regulations described above,
we may comply